(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to the Session State of the Art Lecture: Personalizing treatment for patients with ...

(UroToday.com) The 2025 AUA annual meeting featured a radiation therapy for localized prostate cancer session and a presentation by Dr. Anne Hong discussing the safety of stabilized hyaluronic acid as ...

(UroToday.com) The 2025 AUA annual meeting featured a bladder cancer clinical trials in progress session and a presentation by Dr. Max Kates discussing PIVOT-006, a phase 3, randomized study of ...

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer trials in progress session and a presentation by Dr. Oliver Sartor discussing PSMA-DC, an open-label, multicenter, randomized ...

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. Maha Hussain discussing the clinical, environmental, genetic, and genomic profile of patients ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL between May 30 th and June 3 rd, 2025, was host to a kidney and bladder cancers oral abstract ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago, IL, was host to a kidney and bladder cancers oral abstract session. Dr. Tian Zhang discussed the ...

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer rapid oral abstract session and a presentation by Dr. Shahneen Sandhu discussing the results from EVOLUTION, an investigator ...

(UroToday.com) The 2025 European Association of Urology (EAU) Annual Meeting held in Madrid, Spain was host to the clinically relevant questions in the management of advanced, hormone-sensitive ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to the Oral Abstract Session: Genitourinary Cancer—Prostate, Testicular, and Penile.

(UroToday.com) The 2025 ASCO annual meeting featured a prostate cancer session and a presentation by Dr. David Wise discussing a phase 1 study of gotistobart (BNT316/ONC-392) in combination with ...

(UroToday.com) The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, IL, was host to a prostate, testicular, and penile cancers poster session. Dr. Valentina Marulanda ...